The deal with startup Dren Bio hands Sanofi a so-called myeloid cell engager that would compete with an array of programs ...
We’re still a few months out from the long-awaited return of Ginny & Georgia season 3, but good news keeps on coming. Today, we’ve managed to get our paws on the episode titles for the forthcoming ...
A month has gone by since the last earnings report for Merck (MRK). Shares have added about 3.9% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading up ...
Shares of Merck & Co. Inc. MRK advanced 1.34% to $90.58 Thursday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 1.59% to 5,861. ...
Merck, also known as MSD outside the U.S. and Canada, plans to significantly expand its workforce in India, aiming for around 2,700 employees by the year's end. The company focuses on therapy areas ...
However, this decline, in my opinion, is not critical for Merck's financial position, since sales of Januvia and Janumet account for only 3.1% of its total revenue. As always, Keytruda ...
Mer­ck said its “once-in-a-life­time” drug Keytru­da could be sub­ject to price re­duc­tions un­der the In­fla­tion Re­duc­tion Act, which would lead to a … ...
Merck is bracing for the years of sales growth from oncology superstar Keytruda to take a sharp turn in 2028—and for more reasons than one. Along with a key U.S. patent expiring at the end of ...
Merck (NYSE:MRK) said it expects its top-selling drug, Keytruda, to be selected by the U.S. government for price setting negotiations next year under the Inflation Reduction Act. In a filing with ...
Prometheus Biosciences, which Merck acquired, saw a 31% placebo-adjusted ... The data are informing Sanofi and Teva’s phase 3 plans. Last month, Teva Chief Medical Officer Eric Hughes, M.D ...
At least three people are dead, two are injured and another is missing after a boat capsized in a waterway between Brooklyn and Staten Island on Sunday afternoon, officials said. Five of the six ...